top headlines
The US FDA has approved Revolution Medicines’ daraxonrasib for adults [...]
PharmaForceIQ has launched Optichannel 360, an AI platform that connects [...]
Movers & Shakers
sponsored content
Saama’s Chief Customer Success and Growth Officer Ari Srinivasan speaks [...]
In this exclusive interview with Liza Laws for Discover Pharma, [...]
With 89% of AI pilots failing to scale, biopharmas can [...]
Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]
Other news
Biogen’s felzartamab has been approved in China as a treatment [...]
Circio and Full Circles Therapeutics are combining circular RNA and [...]
Piramal Pharma has reported a 22.6% reduction in Scope 1 [...]
Centrix Pharma Solutions and the University of Sussex are using [...]
START and Allegheny Health Network are establishing a new early-phase [...]
Polaryx Therapeutics is preparing to start its Phase 2 SOTERIA [...]
